ASX:MSB
ASX:MSBBiotechs

Mesoblast (ASX:MSB) Valuation Check After FDA Backs Rexlemestrocel L’s Pain And Opioid Reduction Data

Mesoblast (ASX:MSB) is back in focus after feedback from the U.S. FDA on its rexlemestrocel L cell therapy, which targets chronic discogenic low back pain and is directly linked to opioid use reduction. See our latest analysis for Mesoblast. Despite the positive FDA feedback, Mesoblast’s recent share price momentum has been soft, with a 7 day share price return of a 7.0% decline and a 30 day share price return of a 12.7% decline, while the 3 year total shareholder return of 177.6% points to a...
ASX:JHX
ASX:JHXBasic Materials

A Look At James Hardie Industries’ (ASX:JHX) Valuation As Plant Closures Aim For Future Cost Savings

James Hardie Industries (ASX:JHX) is back in focus after announcing plans to close its Fontana, California, and Summerville, South Carolina manufacturing plants within 60 days and to consolidate capacity under a broader optimization program. See our latest analysis for James Hardie Industries. The plant closures come after a sharp share price rally, with a 15.54% 30 day share price return and a 13.02% year to date share price return, even as the 1 year total shareholder return shows a 36.53%...
ASX:DJW
ASX:DJWCapital Markets

Djerriwarrh Investments H1 2026 Margin Compression Challenges High Quality Earnings Narrative

Djerriwarrh Investments (ASX:DJW) has put out its H1 2026 numbers, reporting total revenue of A$24.8 million and basic EPS of A$0.079, with trailing twelve month EPS of A$0.146 on revenue of A$51.6 million. Over the last three reported halves, revenue has moved between A$24.8 million and A$26.7 million while basic EPS has ranged from A$0.067 to A$0.081. This gives investors a clear view of how earnings per share have tracked relative to a fairly steady top line. With trailing net profit...
ASX:BGL
ASX:BGLMetals and Mining

3 ASX Stocks That May Be Priced Below Their Intrinsic Value Estimates

As the Australian share market faces a slight dip amid global trade tensions and tariff threats, investors are keenly observing opportunities that may arise from these fluctuations. In such an environment, identifying stocks that might be priced below their intrinsic value becomes crucial for those looking to capitalize on potential market inefficiencies.
ASX:PTN
ASX:PTNMetals and Mining

3 ASX Penny Stocks With Market Caps Under A$500M

The Australian stock market is experiencing a slight dip, with shares expected to open 0.3% lower due to global economic factors such as new tariffs from the U.S. on Europe. Despite these challenges, there are still opportunities for investors looking at smaller or newer companies often referred to as penny stocks. While the term may seem outdated, these stocks can offer significant potential when they are backed by strong financials and solid fundamentals, providing an intriguing area of...
ASX:PPS
ASX:PPSSoftware

Undervalued Global Small Caps With Insider Buying In January 2026

As the global markets navigate a mixed landscape, small-cap and value stocks have emerged as leaders, with indices like the Russell 2000 and S&P MidCap 400 reaching all-time highs. This environment highlights the potential for discerning investors to explore opportunities in smaller companies that may be poised for growth amidst broader economic shifts. In this context, identifying small-cap stocks with strong fundamentals and positive insider activity can be a strategic move for those...
ASX:SRG
ASX:SRGConstruction

Promising ASX Penny Stocks To Watch In January 2026

The Australian share market is experiencing a slight downturn, influenced by global trade tensions and recent tariff discussions, yet remains relatively stable compared to European counterparts. Despite the broader market fluctuations, penny stocks continue to capture investor interest as they often represent smaller or newer companies with potential for significant growth. Although the term "penny stock" might seem outdated, these investments can offer unique opportunities when backed by...